Showing results (131-140 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|September 2, 2021
Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissectionD J H Baas, M Schilham, R Hermsen, et al.
Prostate Cancer and Prostatic Diseases|April 30, 2021
Association between vasectomy and risk of prostate cancer: a meta-analysisYawei Xu, Lei Li, Wuping Yang, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2021
Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancerIbrahim M Asiri, Ronald C Chen, Henry N Young, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2021
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution seriesArmando Stabile, Francesco Barletta, Giovanni Motterle, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2015
Replication of a genetic variant for prostate cancer-specific mortalityK L Penney, I M Shui, Z Feng, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2015
The effect of bicycling on PSA levels: a systematic review and meta-analysisD Jiandani, A Randhawa, R E Brown, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2020
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic reviewRaffaele Ratta, Annalisa Guida, Florian Scotté, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2020
Exposure to direct-to-consumer advertising is associated with overestimation of benefits regarding ultrahypofractionated radiation therapy for prostate cancerJoseph M Caputo, Henry J Lee, Bennett Chiles, et al.
Prostate Cancer and Prostatic Diseases|September 14, 2021
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trialsBertrand F Tombal, Stephen J Freedland, Andrew J Armstrong, et al.
Pageof 199